Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Pregabalin CR vs IR and Food Effect in Healthy Males
NCT02783638Phase 1Completed
- Sponsor
- Yuhan
- Start
- Jan 2016
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pregabalin in Peripheral neuropathic pain (2 arms), sponsored by Yuhan. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve over dosing interval. Started Jan 2016; status: completed.
02
Drugs
pregabalin
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT02783638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02783638.